false
OasisLMS
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Catalog
Mechanistic and Clinical Aspects of Benign Thyroid ...
Mechanistic and Clinical Aspects of Benign Thyroid ...
Mechanistic and Clinical Aspects of Benign Thyroid Disease
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Apologies for the confusion in the video content. It appears that there were multiple speakers presenting on different topics related to thyroid disease. The first speaker discussed the predictors of 30-day readmission for hyperthyroidism. The second speaker presented on transcriptional changes in the thyroid related to immune checkpoint inhibition. The third speaker reviewed findings on the structural requirements of thyroglobulin in protein trafficking for thyroid hormoneogenesis. The fourth speaker discussed the use of steroids in the management of destructive thyrotoxicosis induced by PD-1 blockade. And the fifth speaker presented on the impact of teparotumab on disease-related quality of life in patients with Graves' orbitopathy. The content covered various aspects of thyroid disease, including predictors of readmission, immunotherapy-induced thyroid dysfunction, protein trafficking in hormone synthesis, treatment strategies for thyrotoxicosis, and the impact of a targeted therapy on quality of life.
Keywords
thyroid disease
30-day readmission
hyperthyroidism
transcriptional changes
immune checkpoint inhibition
thyroglobulin
protein trafficking
thyroid hormoneogenesis
steroids
×